No Data
No Data
Nuvalent(NUVL.US) Director Sells US$134.44K in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 2,000 shares of common stock on May 28, 2024 at an average price of $67.22 for a total value of $134.44K.Source: Announcement What is statement of chang
Nuvalent to Participate in the 2024 Jefferies Global Healthcare Conference
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...
Nuvalent(NUVL.US) Director Sells US$345.45K in Common Stock
$Nuvalent(NUVL.US)$ Director Conley Emily sold 5,000 shares of common stock on May 15, 2024 at an average price of $69.09 for a total value of $345.45K.Source: Announcement What is statement of change
Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing
Emily Conley, Director, on May 15, 2024, sold 5,000 shares in Nuvalent (NUVL) for $345,450. Following the Form 4 filing with the SEC, Conley has control over a total of 8 shares of the company, with 8
Express News | Wedbush Reiterates Outperform on Nuvalent, Maintains $99 Price Target
Nuvalent Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/17/2024 32.85% Wedbush → $99 Reiterates Outperform → Outperform 04/17/2024 30.17% Jefferies → $97 Initi